Next time, I will leave Greek lunchbox below our poster for my friends @tompowles1 @brian_rini @Uromigos thanks for… https://t.co/3mhxD4whjn
See more from Petros Grivas
We presented data from cohort 1, 2 & 3 of TROPHY-U01 trial (manuscripts coming soon): Cohort 3 with SG/pembro showed ORR 41%, CR 20%, mDOR ~ 11 mo, mPFS ~ 5mo, mOS ~ 13 months; toxicity profile as expected with either agent alone; data support further evaluation of the combo